| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |